| Teruna Siahaan » |
Synthesis and Analysis of CCN5 PEGylated Proteins |
Department of Veterans Affairs Medical Center |
$26,750 |
04/01/2021 |
| David Volkin » |
In vitro and in vivo assessments of Alum-CpG formulation of CoV2 vaccines |
Gates Foundation |
$250,000 |
04/27/2021 |
| Yoshiaki Azuma » |
Role of chromosomal protein remodeling function of PICH in chromosome segregation |
University of Kansas Medical Center Research Institute |
$37,875 |
05/01/2021 |
| Brandon DeKosky » |
Molecular identification and precise therapeutic targeting of anti-insulin B cells in Type I diabetes |
University of Kansas Medical Center Research Institute |
$37,875 |
05/01/2021 |
| Meredith Hartley » |
Regulatory role of nuclear hormone receptors in oligodendrocyte progenitor cell differentiation and myelination |
University of Kansas Medical Center Research Institute |
$25,000 |
05/01/2021 |
| Stuart Macdonald » |
Linking genomic physiological and behavioral responses to copper stress |
University of Kansas Medical Center Research Institute |
$37,875 |
05/01/2021 |
| Stuart Macdonald » |
A Drosophila Resource for the Genetic Analysis of Complex Traits |
University of Kansas Medical Center Research Institute |
$39,405 |
05/01/2021 |
| Wendy Picking » |
Shigella conjugate Immunization study plan (IVT-SHIG-2) |
Inventprise LLC |
$46,807 |
06/01/2021 |
| Heng Du » |
Ghrelin resistance in Alzheimer’s disease |
University of Kansas |
$25,000 |
07/01/2021 |
| Michael Johnson » |
Light-Initiated Zinc Signaling in Parkinson's Disease |
J.R. and Inez Jay Fund |
$25,000 |
07/01/2021 |
| Wendy Picking » |
A Vaccine Specifically Targeting T3SS-negative Pseudomonas Aeruginosa |
National Institutes of Health |
$416,625 |
07/01/2021 |
| William Picking » |
Applying novel approaches to obtain the molecular structures of difficult T3SS proteins |
J.R. and Inez Jay Fund |
$25,000 |
07/01/2021 |
| Eduardo Rosa-Molinar » |
Elucidating and disrupting de novo GBM tumor cell-neuron synapses |
University of Kansas Medical Center Research Institute |
$35,000 |
07/01/2021 |
| Shyam Sathyamoorthi » |
Development of New Antibacterial Agents: A Synthesis of the Antibiotic Enacyloxin IIa for the Generation of Therapeutic Analogues |
J.R. and Inez Jay Fund |
$25,000 |
07/01/2021 |
| Scott Hefty » |
COBRE Chemical Biology of Infectious Disease |
National Institutes of Health |
$11,348,856 |
08/01/2021 |
| Robert Unckless » |
EAGER: Toward a tractable genetic model of DNA virus - Drosophila interaction |
National Science Foundation |
$253,573 |
08/01/2021 |
| Christian Schoeneich » |
Mechanistic Understanding of Polysorbate 20/80 Oxidation Due to Potential Process Related Impurities in Biologic Drug Product |
Eli Lilly Co |
$200,000 |
08/13/2021 |
| Sarah Wu » |
Targeting RNA-binding protein HuR as a novel therapy for lethal prostate cancer |
Department of Defense |
$853,254 |
08/15/2021 |
| Jennifer Robinson » |
Biomaterial technologies for interrogating sex differences in tissue repair and homeostasis |
National Institutes of Health |
$1,850,185 |
09/01/2021 |
| Shyam Sathyamoorthi » |
Tethered aza-Wacker Technology for Complex Antibiotic Assembly |
National Institutes of Health |
$1,864,708 |
09/01/2021 |
